Guangdong Taiantang Pharmaceutical Co., Ltd.
SZSE:002433.SZ
2.69 (CNY) • At close October 26, 2023
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) CNY.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Omzet
| 410.361 | 724.845 | 2,264.175 | 3,581.949 | 4,013.155 | 3,315.298 | 3,238.941 | 3,075.445 | 2,371.648 | 1,227.637 | 785.166 | 517.877 | 417.367 | 314.035 | 288.335 | 243.776 | 182.971 |
Kosten van de omzet
| 341.196 | 442.464 | 1,734.968 | 2,650.291 | 3,033.41 | 2,394.651 | 2,269.657 | 2,245.126 | 1,697.114 | 768.353 | 460.658 | 279.486 | 240.315 | 189.297 | 176.325 | 149.572 | 113.826 |
Brutowinst
| 69.165 | 282.381 | 529.207 | 931.657 | 979.745 | 920.646 | 969.284 | 830.32 | 674.533 | 459.284 | 324.508 | 238.39 | 177.053 | 124.739 | 112.01 | 94.205 | 69.146 |
Brutowinstmarge
| 0.169 | 0.39 | 0.234 | 0.26 | 0.244 | 0.278 | 0.299 | 0.27 | 0.284 | 0.374 | 0.413 | 0.46 | 0.424 | 0.397 | 0.388 | 0.386 | 0.378 |
Onderzoek- en ontwikkelingskosten
| 7.473 | 26.717 | 30.4 | 20.381 | 24.261 | 22.91 | 30.004 | 20.436 | 21.622 | 7.22 | 2.958 | 0.771 | 0.438 | 0.208 | 0 | 0 | 0 |
Algemene en administratieve kosten
| 36.653 | 34.367 | 37.223 | 49.854 | 45.301 | 39.912 | 33.715 | 37.715 | 30.365 | 16.095 | 12.173 | 13.444 | 10.317 | 7.437 | 11.918 | 14.096 | 13.1 |
Verkoop- en marketingkosten
| 217.557 | 117.703 | 369.193 | 549.272 | 511.016 | 446.2 | 350.703 | 334.463 | 295.898 | 131.121 | 93.24 | 51.05 | 59.941 | 40.464 | 28.96 | 29.657 | 18.086 |
Verkoop-, algemene en administratieve kosten
| 254.211 | 152.07 | 406.416 | 599.126 | 556.318 | 486.113 | 384.418 | 372.178 | 326.263 | 147.216 | 105.413 | 64.495 | 70.258 | 47.9 | 40.877 | 43.753 | 31.186 |
Overige kosten
| -71.583 | 140.316 | 180.186 | 165.221 | 152.002 | -0.881 | 49.866 | 29.284 | 3.167 | 4.249 | 3.499 | 9.878 | 1.338 | 2.722 | 5.985 | 0.715 | 0.39 |
Bedrijfskosten
| 427.694 | 319.103 | 617.003 | 784.728 | 732.581 | 666.833 | 553.301 | 501.742 | 443.979 | 222.619 | 155.013 | 106.251 | 91.888 | 60.293 | 42.919 | 45.493 | 32.511 |
Bedrijfsresultaat
| -2,213.852 | -68.887 | -87.796 | 184.954 | 278.413 | 329.47 | 304.333 | 266.12 | 219.119 | 203.538 | 153.052 | 102.668 | 84.81 | 63.644 | 64.705 | 46.462 | 35.193 |
Bedrijfsresultaat ratio
| -5.395 | -0.095 | -0.039 | 0.052 | 0.069 | 0.099 | 0.094 | 0.087 | 0.092 | 0.166 | 0.195 | 0.198 | 0.203 | 0.203 | 0.224 | 0.191 | 0.192 |
Totaal overige inkomsten en kosten netto
| -1,906.996 | -751.43 | -754.43 | -146.911 | -154.299 | 74.776 | -61.784 | -33.43 | -8.447 | -28.88 | -13.012 | -20.188 | 2.38 | 2.556 | -2.061 | -1.535 | -1.052 |
Inkomen voor belasting
| -2,285.435 | -820.317 | -842.226 | 38.044 | 124.115 | 328.59 | 354.199 | 295.148 | 222.108 | 207.786 | 156.483 | 111.952 | 87.544 | 67.001 | 67.03 | 47.177 | 35.583 |
Inkomen voor belasting ratio
| -5.569 | -1.132 | -0.372 | 0.011 | 0.031 | 0.099 | 0.109 | 0.096 | 0.094 | 0.169 | 0.199 | 0.216 | 0.21 | 0.213 | 0.232 | 0.194 | 0.194 |
Belastingkosten
| 9.316 | 33.259 | -10.304 | 11.155 | 22.29 | 53.409 | 59.885 | 42.268 | 26.53 | 15.41 | 19.188 | 21.469 | 13.392 | 10.552 | 13.185 | 7.665 | 5.222 |
Nettowinst
| -2,210.087 | -853.575 | -831.921 | 22.226 | 96.094 | 270.892 | 290.399 | 243.328 | 190.124 | 186.307 | 132.897 | 88.054 | 74.153 | 56.449 | 53.891 | 38.285 | 30.705 |
Nettowinstmarge
| -5.386 | -1.178 | -0.367 | 0.006 | 0.024 | 0.082 | 0.09 | 0.079 | 0.08 | 0.152 | 0.169 | 0.17 | 0.178 | 0.18 | 0.187 | 0.157 | 0.168 |
WPA (Winst Per Aandeel)
| -2.88 | -1.11 | -1.08 | 0.029 | 0.13 | 0.35 | 0.38 | 0.32 | 0.26 | 0.3 | 0.24 | 0.22 | 0.19 | 0.16 | 0.18 | 0.13 | 0.12 |
Verwaterde WPA
| -2.88 | -1.11 | -1.08 | 0.029 | 0.13 | 0.35 | 0.32 | 0.31 | 0.26 | 0.3 | 0.24 | 0.22 | 0.19 | 0.16 | 0.18 | 0.13 | 0.12 |
EBITDA
| -312.926 | 58.863 | -0.261 | 291.083 | 374.037 | 603.524 | 542.316 | 414.811 | 291.835 | 297.16 | 214.854 | 168.144 | 106.824 | 78.28 | 75.897 | 52.637 | 43.845 |
EBITDA ratio
| -0.763 | 0.081 | -0 | 0.081 | 0.093 | 0.182 | 0.167 | 0.135 | 0.123 | 0.242 | 0.274 | 0.325 | 0.256 | 0.249 | 0.263 | 0.216 | 0.24 |